Burk KS, Knipp D, Sahani DV. Cystic pancreatic tumors. Magn Reson Imaging Clin N Am. 2018;26:405–20.
Buerke B. Schülke C: [Cystic lesions of the pancreas]. Radiologe. 2015;55:145–56 quiz 157.
Reddy S, Wolfgang CL. Benign pancreatic tumors. Surg Clin North Am. 2007;87:1359–78 viii.
Adsay NV, Basturk O, Klimstra DS, Klöppel G. Pancreatic pseudotumors: non-neoplastic solid lesions of the pancreas that clinically mimic pancreas cancer. Semin Diagn Pathol. 2004;21:260–7.
Okun SD, Lewin DN. Non-neoplastic pancreatic lesions that may mimic malignancy. Semin Diagn Pathol. 2016;33:31–42.
Gandhi NS, Feldman MK, Le O, Morris-Stiff G. Imaging mimics of pancreatic ductal adenocarcinoma. Abdom Radiol (NY). 2018;43:273–84.
Kaur S, Smith LM, Patel A, Menning M, Watley DC, Malik SS, et al. A combination of MUC5AC and CA19-9 improves the diagnosis of pancreatic cancer: a multicenter study. Am J Gastroenterol. 2017;112:172–83.
Luo G, Jin K, Deng S, Cheng H, Fan Z, Gong Y, et al. Roles of CA19-9 in pancreatic cancer: biomarker, predictor and promoter. Biochim Biophys Acta Rev Cancer. 2021;1875:188409.
Zeng P, Li H, Chen Y, Pei H, Zhang L. Serum CA199 levels are significantly increased in patients suffering from liver, lung, and other diseases. Prog Mol Biol Transl Sci. 2019;162:253–64.
Luo G, Fan Z, Cheng H, Jin K, Guo M, Lu Y, et al. New observations on the utility of CA19-9 as a biomarker in Lewis negative patients with pancreatic cancer. Pancreatology. 2018;18:971–6.
Chang CC, Liou CB, Su MJ, Lee YC, Liang CT, Ho JL, et al. Creatine kinase (CK)-MB-to-total-CK ratio: a laboratory indicator for primary cancer screening. Asian Pac J Cancer Prev. 2015;16:6599–603.
Tsung JS. Creatine kinase and its isoenzymes in neoplastic disease. Crit Rev Clin Lab Sci. 1986;23:65–75.
Papalazarou V, Zhang T, Paul NR, Juin A, Cantini M, Maddocks ODK, et al. The creatine-phosphagen system is mechanoresponsive in pancreatic adenocarcinoma and fuels invasion and metastasis. Nat Metab. 2020;2:62–80.
Zarghami N, Giai M, Yu H, Roagna R, Ponzone R, Katsaros D, et al. Creatine kinase BB isoenzyme levels in tumour cytosols and survival of breast cancer patients. Br J Cancer. 1996;73:386–90.
Pan H, Xia K, Zhou W, Xue J, Liang X, Cheng L, et al. Low serum creatine kinase levels in breast cancer patients: a case-control study. PLoS One. 2013;8:e62112.
Halfdanarson TR, Rubin J, Farnell MB, Grant CS, Petersen GM. Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors. Endocr Relat Cancer. 2008;15:409–27.
Bais R, Edwards JB. Creatine kinase. Crit Rev Clin Lab Sci. 1982;16:291–335.
Frank M, Finsterer J. Creatine kinase elevation, lactacidemia, and metabolic myopathy in adult patients with diabetes mellitus. Endocr Pract. 2012;18:387–93.
Kanda M, Fujii T, Kodera Y, Nagai S, Takeda S, Nakao A. Nutritional predictors of postoperative outcome in pancreatic cancer. Br J Surg. 2011;98:268–74.
Klöppel G, Adsay NV. Chronic pancreatitis and the differential diagnosis versus pancreatic cancer. Arch Pathol Lab Med. 2009;133:382–7.
Kim JK, Altun E, Elias J Jr, Pamuklar E, Rivero H, Semelka RC. Focal pancreatic mass: distinction of pancreatic cancer from chronic pancreatitis using gadolinium-enhanced 3D-gradient-echo MRI. J Magn Reson Imaging. 2007;26:313–22.
Wilson RH, Chandra M, Scheiman JM, Lee SY, Lee OE, McKenna BJ, et al. Tissue classification using optical spectroscopy accurately differentiates cancer and chronic pancreatitis. Pancreas. 2017;46:244–51.
Navaneethan U, Spencer C, Zhu X, Vargo JJ, Grove D, Dweik RA. Volatile organic compounds in bile can distinguish pancreatic cancer from chronic pancreatitis: a prospective observational study. Endoscopy. 2021;53:732–6.
Goh BK, Tan DM, Chan CY, Lee SY, Lee VT, Thng CH, et al. Are preoperative blood neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios useful in predicting malignancy in surgically-treated mucin-producing pancreatic cystic neoplasms? J Surg Oncol. 2015;112:366–71.
Gemenetzis G, Bagante F, Griffin JF, Rezaee N, Javed AA, Manos LL, et al. Neutrophil-to-lymphocyte ratio is a predictive marker for invasive malignancy in intraductal papillary mucinous neoplasms of the pancreas. Ann Surg. 2017;266:339–45.
Maisonneuve P, Lowenfels AB. Epidemiology of pancreatic cancer: an update. Dig Dis. 2010;28:645–56.
Szasz G, Busch EW. Farohs HB: [Serum creatine kinase. I. Methodical experience and normal values with a new commercial test]. Dtsch Med Wochenschr. 1970;95:829–35.
Thomson WH. Determination and statistical analyses of the normal ranges for five serum enzymes. Clin Chim Acta. 1968;21:469–78.
Hess JW, MacDonald RP, Natho GJ, Murdock KJ. Serum creatine phosphokinase: evaluation of a commercial spectrophotometric method. Clin Chem. 1967;13:994–1005.
Baracos VE, Martin L, Korc M, Guttridge DC, Fearon KCH. Cancer-associated cachexia. Nat Rev Dis Primers. 2018;4:17105.
Weber MA, Kinscherf R, Krakowski-Roosen H, Aulmann M, Renk H, Künkele A, et al. Myoglobin plasma level related to muscle mass and fiber composition: a clinical marker of muscle wasting? J Mol Med (Berl). 2007;85:887–96.
Takamori S, Toyokawa G, Shimokawa M, Kinoshita F, Kozuma Y, Matsubara T, et al. A novel prognostic marker in patients with non-small cell lung cancer: musculo-immuno-nutritional score calculated by controlling nutritional status and creatine kinase. J Thorac Dis. 2019;11:927–35.
Poulia KA, Sarantis P, Antoniadou D, Koustas E, Papadimitropoulou A, Papavassiliou AG, et al. Pancreatic cancer and cachexia-metabolic mechanisms and novel insights. Nutrients. 2020;12(6):1543.
Bera S, Ray M. The transcriptional cascade associated with creatine kinase down-regulation and mitochondrial biogenesis in mice sarcoma. Cell Mol Biol Lett. 2009;14:481–96.
Guttridge DC, Mayo MW, Madrid LV, Wang CY, Baldwin AS Jr. NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia. Science. 2000;289:2363–6.
Schneider CM, Dennehy CA, Rodearmel SJ, Hayward JR. Effects of physical activity on creatine phosphokinase and the isoenzyme creatine kinase-MB. Ann Emerg Med. 1995;25:520–4.
Wei B, Yao M, Xing C, Wang W, Yao J, Hong Y, et al. The neutrophil lymphocyte ratio is associated with breast cancer prognosis: an updated systematic review and meta-analysis. Onco Targets Ther. 2016;9:5567–75.
Dolan RD, McSorley ST, Horgan PG, Laird B, McMillan DC. The role of the systemic inflammatory response in predicting outcomes in patients with advanced inoperable cancer: systematic review and meta-analysis. Crit Rev Oncol Hematol. 2017;116:134–46.
Li J, Cao G, Ma Q, Liu H, Li W, Han L. The bidirectional interation between pancreatic cancer and diabetes. World J Surg Oncol. 2012;10:171.
Gan C, Zhang Y, Liang F, Guo X, Zhong Z. Effects of APOE gene ε4 allele on serum lipid profiles and risk of cardiovascular disease and tumorigenesis in southern Chinese population. World J Surg Oncol. 2022;20:280.
Liu L, He Y, Ge G, Li L, Zhou P, Zhu Y, et al. Lactate dehydrogenase and creatine kinase as poor prognostic factors in lung cancer: a retrospective observational study. PLoS One. 2017;12:e0182168.
Murayama K, Suzuki T, Yajima S, Oshima Y, Nanami T, Shiratori F, et al. Preoperative low serum creatine kinase is associated with poor overall survival in the male patients with esophageal squamous cell carcinoma. Esophagus. 2022;19:105–12.